【24h】

Recognition templates for biomaterials with engineered bioreactivity

机译:生物材料的识别模板,具有工程生物的生物材料

获取原文

摘要

Biology ubiquitously uses molecular recognition and specificity to do its work. In contrast, the biomaterials widely used in medicine today non-specifically adsorb complex protein mixtures to their surfaces. These ill-defined protein layers are "read" by the cells (neutrophils, macrophages) that interrogate the implanted materials - the protein coat may be the trigger of subsequent biological reactions. Given the heterogeneity in composition (there are 200+ proteins in blood) and organization (proteins are adsorbed with no control of orientation or conformation) of adsorbed protein layers, it is no surprise that biological reactions, particularly in vivo, are poorly controlled. If fact, implanted synthetic materials are almost universally seen by the body as foreign objects and walled off into a tough, avascular, collagenous bag1. Medical implants are widely used clinically and save lives and improve the quality of life for millions (Table 1). Medical implants are primarily fabricated from synthetic materials (polymers, metals, ceramics, glasses). These implants are walled off from the body within 3 weeks of implantation as described above. This implant encapsulation can impede the healing and performance of many devices. Capsule formation around implants may be a manifestation of the lack of recognition by the body of the nonspecifically adsorbed proteins coating the implant. In contrast to synthetic materials, biological tissue and normal wounds heal by a different process. Normal wound healing and integration are characterized by the absence of a collagenous capsule, new blood vessel formation and reconstruction of damaged tissues. Obviously, this normal reconstruction should be preferable to the aberrant, capsular healing noted with modern, "biocompatible" biomaterials. Is it possible to convert synthetic biomaterials to materials that will heal in the body by controlling the non-specific protein adsorption and thus use the surfaces of materials to deliver correct healing signals to the body? The approach of increasing the recognition and specificity of biomaterial surfaces is being pursued in our research group. With appropriate recognition structures on biomaterials, we may be able turn on normal healing rather having the biomaterial targeted as foreign.
机译:生物学普遍地使用分子识别和特异性来完成其工作。相反,今天广泛用于医学的生物材料是非特别吸附复合蛋白质混合物在其表面上。这些不含鉴定的蛋白质层由询问植入材料的细胞(中性粒细胞,巨噬细胞)“读取” - 蛋白质涂层可以是随后的生物反应的触发。鉴于组合物中的异质性(血液中有200多种蛋白质)和组织(蛋白质吸附着无吸附或构象的血液)的吸附蛋白质层,毫不奇怪的是,生物反应,特别是体内,较差。如果事实上,植入的合成材料几乎被身体普遍看过了外来物体,并围绕着坚韧,刺穿,胶原袋1。医疗植入物在临床上广泛使用,挽救生命,提高数百万的生活质量(表1)。医疗植入物主要由合成材料(聚合物,金属,陶瓷,玻璃)制成。如上所述,这些植入物在植入的3周内从身体围绕。这种植入物封装可以妨碍许多设备的愈合和性能。植入物周围形成的胶囊形成可以是非特异性吸附蛋白的体内缺乏识别植入物的表现。与合成材料相反,生物组织和正常伤口通过不同的方法愈合。通过胶原胶囊,新的血管形成和受损组织的重建,表征正常伤口愈合和整合。显然,这种正常重建应优选具有现代,“生物相容性”生物材料的异常,囊状愈合。是否可以通过控制非特异性蛋白质吸附来将合成生物材料转化为将在体内愈合的材料,从而使用材料表面向身体提供正确的愈合信号?在我们的研究组中正在追求增加生物材料表面的识别和特异性的方法。在生物材料上具有适当的识别结构,我们可能能够转动正常愈合而不是将生物材料靶向外国。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号